Programme
12.30   Registration
13.00 Workshop introduction
13.15 The application of mouse models humanised for the cytochrome P450 system to study drug/drug interactions - our experience with small molecules as well as the models potential for testing of peptides
Roland Wolf, University of Dundee, Scotland
14.00 DDI assessment of therapeutic peptides
Carolina Säll, NovoNordisk, Denmark
14.35 ADME studies for peptides: what studies make sense from European regulatory perspective
Anna Nordmark, Scandinavian Development Services, Sweden
15.10 Coffee break
15.40 Metabolism and oligomerization in the subcutaneaous compartment. Impact on the bioavailability of therapeutic peptides  
Edith Monteagudo, IRBM, Italy
16.15 Experiences within regulated bioanalysis of using a hybrid immunocapture LC-MS/MS approach for peptide quantification
Jonathan Griffin, Zealand Pharma, Denmark
16.50 Neprilysin and Megalin - Two for tragedy in peptidic radiopharmaceuticals development?
Jan Ungewiss, 3B Pharmaceuticals, Germany
17.25 Free session discussion/meeting roundup
19.00 Drinks/dinner (at own expense)